Search research articles
Contact Us
Filters
Showing results (41-50 of 107) with videos related to
Page
of 11
Sort By:
Elife
|
May 10, 2021
Chromatin structure-dependent histone incorporation revealed by a genome-wide deposition assay
Hiroaki Tachiwana, Mariko Dacher, Kazumitsu Maehara, et al.
Cancer Science
|
August 11, 2022
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer
Takuya Sakashita, Noriko Yanagitani, Sumie Koike, et al.
Cancer Research
|
October 19, 2007
Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo
Emi Tokuda, Naoya Fujita, Tomoko Oh-hara, et al.
NPJ Precision Oncology
|
November 17, 2024
Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer
Takaaki Fujimura, Koh Furugaki, Hayato Mizuta, et al.
Andrology
|
November 21, 2024
Inhibition of ROS1 activity with lorlatinib reversibly suppresses fertility in male mice
Yuki Oyama, Kentaro Shimada, Haruhiko Miyata, et al.
Biochemical and Biophysical Research Communications
|
March 21, 2024
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis
Mai Nagasaka, Chiharu Miyajima, Yasumichi Inoue, et al.
Glycobiology
|
December 11, 2024
Identification of C-mannosylation in a receptor tyrosine kinase AXL
Kento Mori, Takehiro Suzuki, Urara Waki, et al.
Cancer Letters
|
June 20, 2022
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma
Yuki Shimizu, Kohei Maruyama, Mai Suzuki, et al.
Respiratory Medicine Case Reports
|
April 19, 2021
A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation
Tomoyo Oguri, Shinji Sasada, Sachiko Seki, et al.
Chemmedchem
|
January 31, 2026
Concerted pH-Responsive Performance of Chitosan-Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption
Watunyu Thanongsak, Marie Kawahara, Masahiko Nakamoto, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 107) with videos related to
Sort By:
Page
of 11
Elife
|
May 10, 2021
Chromatin structure-dependent histone incorporation revealed by a genome-wide deposition assay
Hiroaki Tachiwana, Mariko Dacher, Kazumitsu Maehara, et al.
Cancer Science
|
August 11, 2022
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer
Takuya Sakashita, Noriko Yanagitani, Sumie Koike, et al.
Cancer Research
|
October 19, 2007
Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo
Emi Tokuda, Naoya Fujita, Tomoko Oh-hara, et al.
NPJ Precision Oncology
|
November 17, 2024
Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer
Takaaki Fujimura, Koh Furugaki, Hayato Mizuta, et al.
Andrology
|
November 21, 2024
Inhibition of ROS1 activity with lorlatinib reversibly suppresses fertility in male mice
Yuki Oyama, Kentaro Shimada, Haruhiko Miyata, et al.
Biochemical and Biophysical Research Communications
|
March 21, 2024
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis
Mai Nagasaka, Chiharu Miyajima, Yasumichi Inoue, et al.
Glycobiology
|
December 11, 2024
Identification of C-mannosylation in a receptor tyrosine kinase AXL
Kento Mori, Takehiro Suzuki, Urara Waki, et al.
Cancer Letters
|
June 20, 2022
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma
Yuki Shimizu, Kohei Maruyama, Mai Suzuki, et al.
Respiratory Medicine Case Reports
|
April 19, 2021
A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation
Tomoyo Oguri, Shinji Sasada, Sachiko Seki, et al.
Chemmedchem
|
January 31, 2026
Concerted pH-Responsive Performance of Chitosan-Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption
Watunyu Thanongsak, Marie Kawahara, Masahiko Nakamoto, et al.
Page
of 11